MAPS speaks with Annemarie Clegg, CMO, OPEN Health, about the evolving role of Medical Affairs in providing context for payers, regulators and policy makers whose decisions can dramatically affect which patients can access industry innovations.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
One of the pandemic’s silver linings may well be gains in participation levels and the volume and quality of insights generated by eliminating the constraints of face-to-face interaction.
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.
In this installment of the Leadership Perspectives series, we speak with some of the top Medical Affairs leaders from Johnson & Johnson as they think about the rapid new ascension of Medical Affairs into a fully integrated strategic business partner.
Here John Pracyk, MD, PhD, MBA, MAPS President of the Americas Region speaks with some of the top Medical Affairs leaders from Johnson & Johnson as they share their perspective on the impact of Digital on Healthcare.
MAPS speaks with Ariel Katz, co-founder and CEO of H1, about the future of the Medical Affairs function and the factors driving the current pace of change.
In a field where all professionals are esteemed intellectuals, the difference between a middling unknown and a Jeff Bezos is purely emotional intelligence.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.